MetaCap

Prelude Therapeutics Statistics

NASDAQ: PRLDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.23-0.025 (-0.77%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Prelude Therapeutics by the numbers

Prelude Therapeutics has a market capitalization of $258.6 million based on 65.34M shares outstanding. With trailing EPS of $-0.59, Prelude Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.6% below its 50-day average and 21.8% below its 200-day average.

Average daily trading volume is 432.74K shares, or about $1.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

PRLD valuation vs. peer median

PRLD compared with the median of 8 peer companies
MetricPRLDPeer medianDifference
Market cap$258.63M$259.23M-0%
Avg. volume432.74K553.65K-22%

Peer median across 8 companies: EBS, ALT, VCRE, GALT, QTTB, TTRX, LFCR, RLMD.

Valuation

Market cap
$258.63M
Price / sales (latest FY)
21.30
EPS (TTM)
$-0.59

Price and trading

Previous close
3.26
Open
3.21
Day range
3.17 – 3.30
52-week range
1.30 – 6.83
52-week change
+93.41%
Beta
—
Volume
299.25K

Dividends and events

Annual dividend
None
Next earnings date
Nov 16, 2026

Additional statistics

Market Cap
258.63M
Forward Pe
-7.08
Eps
-0.59
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
6.83
Week52 Low
1.30
Avg Volume
432.74K
Shares Outstanding
65.34M
Ma50
3.83
Ma200
4.13
Earnings Date
Nov 16, 2026
Pct From52w High
-52.71%
Pct From52w Low
149.42%

Related